Treatment of dystonia
Top Cited Papers
- 1 October 2006
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (10) , 864-872
- https://doi.org/10.1016/s1474-4422(06)70574-9
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- SV2 Is the Protein Receptor for Botulinum Neurotoxin AScience, 2006
- The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nervesFEBS Letters, 2006
- Bilateral Deep-Brain Stimulation of the Globus Pallidus in Primary Generalized DystoniaNew England Journal of Medicine, 2005
- Heterozygous mutation in 5?-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonianeurogenetics, 2004
- Utilization and perceived effectiveness of complementary and alternative medicine in patients with dystoniaMovement Disorders, 2003
- Myoclonus–dystonia syndrome: ε‐sarcoglycan mutations and phenotypeAnnals of Neurology, 2002
- Hand orthosis as a writing aid in writer's crampMovement Disorders, 2001
- Morphine in tardive and idiopathic dystoniaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2001
- Dystonia in Wilson's diseaseMovement Disorders, 2001
- Mexiletine in the treatment of spasmodic torticollisMovement Disorders, 1998